Can We Treat Neuroinflammation in Alzheimer’s Disease?
نویسندگان
چکیده
منابع مشابه
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Over the past few decades, research on Alzheimer's disease (AD) has focused on pathomechanisms linked to two of the major pathological hallmarks of extracellular deposition of beta-amyloid peptides and intra-neuronal formation of neurofibrils. Recently, a third disease component, the neuroinflammatory reaction mediated by cerebral innate immune cells, has entered the spotlight, prompted by find...
متن کاملHow Can We Treat Cancer Disease Not Cancer Cells?
Since molecular biology studies began, researches in biological science have centered on proteins and genes at molecular level of a single cell. Cancer research has also focused on various functions of proteins and genes that distinguish cancer cells from normal cells. Accordingly, most contemporary anticancer drugs have been developed to target abnormal characteristics of cancer cells. Despite...
متن کاملCan We Use Nanotechnology to Treat Cancer?
Could the next big change in cancer treatment actually be tiny? There are many reasons that cancer is such a difficult disease to treat. Scientists can either try to come up with new and better cancer medicines or they can find better ways for cancer patients to receive their medicines. This paper describes a possible new way to deliver cancer medicines using something called nanoparticles – ti...
متن کاملReactive Oxygen Species, Redox Signaling and Neuroinflammation in Alzheimers Disease: The NF-kappa B Connection
Oxidative stress and inflammatory response are important elements of Alzheimer's disease (AD) pathogenesis, but the role of redox signaling cascade and its cross-talk with inflammatory mediators have not been elucidated in details in this disorder. The review summarizes the facts about redox-signaling cascade in the cells operating through an array of kinases, phosphatases and transcription fac...
متن کاملCytokine dysregulation in chronic kidney disease: how can we treat it?
As the kidney is the major site for elimination of many cytokines, the delicate equilibrium of pro-inflammatory cytokines and their inhibitors is clearly dysregulated in chronic kidney disease (CKD) patients. The consequences of the altered immune response in uremia lead to a state of persistent inflammation which is highly prevalent among CKD patients and is linked to complications such as the...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Molecular Sciences
سال: 2020
ISSN: 1422-0067
DOI: 10.3390/ijms21228751